Myriad Genetics Inc. share price logo

Myriad Genetics Inc. Share Price

NASDAQ: MYGN

Small Cap

$4.61

-0.05

(-1.18%)

as on

Myriad Genetics Inc. Stock Performance

as on March 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.55
    $4.79
    downward going graph

    1.30%

    Downside

    3.90%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.76
    $10.26
    downward going graph

    18.44%

    Downside

    122.45%

    Upside

    downward going graph

Myriad Genetics Inc. share price movements today

Previous Close
$4.66
Open
$4.62
Volume
1.4M
Day's Low - High
$4.55 - $4.79
52 Week Low - High
$3.76 - $10.26

Myriad Genetics Inc. Historical Returns

1 Month Return
-2.51 %
3 Month Return
-28.85 %
1 Year Return
-52.11 %
3 Year Return
-80.35 %
5 Year Return
-84.35 %

Myriad Genetics Inc. Stock Fundamentals & Key Indicators

Check Myriad Genetics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$428.3M

EPS (TTM)

0.059

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-16.57

Industry PE ratio

7.867522123893806

PEG Ratio

1.4001

EBITDA

-14.1M

Revenue (TTM)

824.5M

Profit Margin

-44.38%

Return On Equity TTM

-68.45%

Myriad Genetics Inc. Stock Valuation

Track how Myriad Genetics Inc. P/E has moved over time to understand its valuation trends.

Myriad Genetics Inc. in the last 5 years

  • Overview

  • Trends

Lowest (-137.58x)

June 30, 2021

Today (-16.57x)

March 25, 2026

Industry (7.87x)

March 25, 2026

Highest (193.36x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -16.57x

Myriad Genetics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Myriad Genetics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Myriad Genetics Inc. image
Myriad Genetics Inc.
BUY$428.3M-84.35%-16.57-44.38%
Idexx Laboratories, Inc. image
Idexx Laboratories, Inc.
BUY$46.1B22.54%44.0724.62%
Waters Corporation image
Waters Corporation
HOLD$29.6B10.55%28.0520.30%
Thermo Fisher Scientific, Inc. image
Thermo Fisher Scientific, Inc.
BUY$176.2B8.1%26.7415.05%
Agilent Technologies Inc. image
Agilent Technologies Inc.
BUY$31.7B-8.11%24.7318.26%
See all

Stock Returns calculator for Myriad Genetics Inc. Stock including INR - Dollar returns

The Myriad Genetics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Myriad Genetics Inc. investment value today

Current value as on today

₹56,920

Returns

₹43,080

(-43.08%)

Returns from Myriad Genetics Inc. Stock

₹52,621 (-52.62%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Myriad Genetics Inc. Stock

Based on 18 analysts

BUY

50.00%

Buy

33.33%

Hold

16.67%

Sell

Based on 18 analysts, 50% of analysts recommend a 'BUY' rating for Myriad Genetics Inc.. Average target price of $7.78

Myriad Genetics Inc. Share Price Target

Get share price movements and forecasts by analysts on Myriad Genetics Inc..

What analysts predicted

40.75%UPSIDE

Target Price

$7.78

Current Price

$4.61

Analyzed by

18 Analysts

Target

$7.78

Myriad Genetics Inc. target price $7.78, a slight upside of 40.75% compared to current price of $4.61. According to 18 analysts rating.

Myriad Genetics Inc. Stock’s Investor Sentiment and Interest

Search interest for Myriad Genetics Inc. Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Myriad Genetics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
191
196
202
211
213
210
195
213
205
209
Gross Profit
134
135
137
147
149
150
134
151
143
146
Operating Income
-60
-31
-27
-36
-20
-39
-29
-329
-23
120
EBITDA
-46
-16
-9
-21
-4
-23
-14
-315
-9
-60
Interest Expense
1
0
0
0
0
0
0
1
3
4
Depreciation
14
15
15
15
15
14
14
14
12
12
Income Before Tax
-61
-32
-25
-37
-21
-39
-29
-330
-26
-8
Income Tax Expense
0
-1
0
0
0
3
-29
0
1
-1
Net Income
-61
-31
-26
-36
-22
-42
0
-330
-27
-7
Net Profit Margin
-31.94%
-15.87%
-12.86%
-17.35%
-10.36%
-20.18%
-0.05%
-155.09%
-13.32%
-3.77%

Myriad Genetics Inc. Annual Profit & Loss

All numbers in Millions USD

Jun 2020
Dec 2020
Jun 2021
Dec 2021
Jun 2022
Dec 2022
Jun 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
851
557
557
690
690
678
678
753
837
824
Gross Profit
-
378
-
493
-
476
-
517
585
576
Operating Income
-
-194
-
-190
-
-140
-
-257
-123
-139
EBITDA
-
-123
-
12
-
-84
-
-197
-59
-397
Interest Expense
-
10
-
6
-
3
-
2
2
12
Depreciation
-
-
-
62
-
52
-
61
61
53
Income Before Tax
-
-283
-
-57
-
-140
-
-262
-123
-395
Income Tax Expense
-
59
-
-29
-
-28
-
1
3
-29
Net Income
4
-223
-223
-27
-27
-112
-112
-263
-127
-365
Net Profit Margin
0.54%
-40.16%
-40.16%
-3.94%
-3.94%
-16.51%
-16.51%
-34.96%
-15.20%
-44.38%

Myriad Genetics Inc. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-31
-26
-36
-22
-42
0
-330
-27
-7
Operating Cash Flow
-54
-18
2
0
6
-16
-13
21
10
Investing Cash Flow
-12
-7
-6
7
-5
-8
-6
-6
-6
Financing Cash Flow
121
-8
2
-3
2
13
2
56
-8
Change in Cash
55
-35
-4
8
2
-10
-17
71
-3

Myriad Genetics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
17
133
4
4
-27
-112
-263
-127
-365
Operating Cash Flow
106
115
83
83
18
-106
-110
-8
1
Investing Cash Flow
-146
-11
-286
19
274
-77
31
-11
-27
Financing Cash Flow
71
-95
182
182
-150
-8
152
-7
64
Change in Cash
33
8
-17
-17
141
-192
74
-29
39

Global Institutional Holdings in Myriad Genetics Inc.

Funds
Holdings
Fisher Asset Management, LLC
1.29%
Millennium Management LLC
5.08%
Northern Trust Corp
1.21%
AQR Capital Management LLC
1.71%
BlackRock Inc
15.91%
See all

Myriad Genetics Inc. News & Key Events

  • img

    Today's Timeline - 24 February

    Tue, 06:15 PM

    -

    Myriad Genetics reports Q4 2025 earnings, adjusted profit of $0.04 per share, exceeding expectations.

    Tue, 09:56 PM

    -

    Shares of Myriad Genetics rise 4.9% after better-than-expected earnings report and positive outlook.

Insights on Myriad Genetics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 205.7M → 209.8M (in $), with an average increase of 2.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -330.5M → -7.9M (in $), with an average increase of 676.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Idexx Laboratories, Inc. has given 38.5% return, outperforming this stock by 90.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Idexx Laboratories, Inc. has given 19.2% return, outperforming this stock by 99.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, MYGN stock has moved down by -28.9%

About Myriad Genetics Inc.

myriad genetics inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. myriad is focused on three strategic imperatives: maintaining leadership in an expanding hereditary cancer market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. for more information on how myriad is making a difference, please visit the company's website: www.myriad.com.
OrganisationMyriad Genetics Inc.
Headquarters322 North 2200 West, Salt Lake City, UT, United States, 84116
IndustryHealth Technology
CEOMr. Samraat S. Raha
E-voting on sharesClick here to vote

Key Management of Myriad Genetics Inc.

Name

Title

Dr. Patrick M. Burke Ph.D.

Executive Vice President of Innovation & Strategic Partnerships

Mr. Samraat S. Raha

President, CEO & Director

Mr. Paul J. Diaz J.D.

Consultant & Director

Mr. Matthew Scalo

Senior Vice President of Investor Relations

Ms. Shereen Solaiman

Chief People Officer

Dr. Thomas P. Slavin M.D.

Chief Medical Officer

Mr. Mark S. Verratti

Chief Operating Officer

Dr. Dale Muzzey Ph.D.

Chief Scientific Officer

Mr. Benjamin R. Wheeler

CFO & Principal Accounting Officer

Ms. Jennifer L. Fox J.D.

Chief Legal Officer

FAQs

What is Myriad Genetics Inc. share price today?

Myriad Genetics Inc. share price today is $4.61 as on at the close of the market. Myriad Genetics Inc. share today touched a day high of $4.79 and a low of $4.55.

What is the 52 week high and 52 week low for Myriad Genetics Inc. share?

Myriad Genetics Inc. share touched a 52 week high of $10.26 on and a 52 week low of $3.76 on . Myriad Genetics Inc. stock price today i.e. is closed at $4.61,which is 55.05% down from its 52 week high and 22.61% up from its 52 week low.

What is Myriad Genetics Inc.'s market capitalisation today?

Myriad Genetics Inc. market capitalisation is $0.00T as on .

How to invest in Myriad Genetics Inc. Stock (MYGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Myriad Genetics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Myriad Genetics Inc. Shares that will get you 0.3254 shares as per Myriad Genetics Inc. share price of $4.61 per share as on March 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Myriad Genetics Inc. Stock (MYGN) from India?

Indian investors can start investing in Myriad Genetics Inc. (MYGN) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Myriad Genetics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Myriad Genetics Inc. share’s latest price of $4.61 as on March 25, 2026 at 1:29 am IST, you will get 2.1692 shares of Myriad Genetics Inc.. Learn more about fractional shares .

What are the returns that Myriad Genetics Inc. has given to Indian investors in the last 5 years?

Myriad Genetics Inc. stock has given -84.35% share price returns and 28.4% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?